🇺🇸 FDA
Patent

US 8343725

Method of diagnosing poor survival prognosis colon cancer using miR-10a

granted A61PA61P1/04A61P35/00

Quick answer

US patent 8343725 (Method of diagnosing poor survival prognosis colon cancer using miR-10a) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P35/00